Navigation Links
Current and Emerging Drugs Have No Advantage Over Enbrel in Inhibiting/Slowing the Progression of Rheumatoid Arthritis
Date:4/7/2008

Although Some Emerging Therapies Hold Promise, Enbrel Will Remain the

Clinical Gold Standard Through 2016, According to a New Report from

Decision Resources

WALTHAM, Mass., April 7, 2008 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that a drug's effect on inhibiting/slowing the progression of structural damage and reducing the signs and symptoms of rheumatoid arthritis during the first year of treatment are the attributes that most influence surveyed rheumatologists' prescribing decisions in the treatment of the disease. Clinical data and expert opinion shows that current and emerging therapies have no advantage in these attributes over the market sales leader, Amgen/Wyeth/Takeda's Enbrel.

The new report entitled Rheumatoid Arthritis: Competitive, Crowded Market Sets the Bar High for Novel Agents finds that, through 2016, there are no therapies in development that will displace Enbrel as the clinical gold standard treatment for rheumatoid arthritis. While some therapies in development for the disease hold promise, most have efficacy, safety and tolerability, and/or delivery features that are inferior when compared with Enbrel.

The overall efficacy of emerging therapies such as Centocor/Schering-Plough/Mitsubishi Tanabe/Janssen's golimumab and Biogen Idec/Genentech/Roche's ocrelizumab is comparable to that of Enbrel, while the overall safety and tolerability for emerging therapies that include ocrelizumab and UCB's Cimzia are also comparable to that of Enbrel. However, the currently available clinical data for golimumab, ocrelizumab and Cimzia is not as robust or extensive as those available for Enbrel.

"While emerging therapies such as golimumab and Cimzia offer superior delivery to that of Enbrel due to improved dosing frequencies, these agents' overall efficacy, safety and tolerability, respect
'/>"/>

SOURCE Decision Resources, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. CV Therapeutics Anti-Ischemic Therapy Ranexa(R) Significantly Reduces Cardiac Chest Pain Symptoms and Recurrent Ischemia in MERLIN-TIMI 36 Patients With Angina
2. Jazz Pharmaceuticals, Inc. Announces Receipt of FDA Orphan Drug Designation for Recurrent Acute Repetitive Seizures Product Candidate
3. Enrollment of Women in Cardiovascular Trials Fails to Meet Current Federal Mandates
4. Oncology Drugs Development Update - Worldwide Markets and Forecasts of Approved EGFr/HEr2 Inhibitors, Treatment Costs, Pathway Analysis, Current and Expanded Clinical Indications, and Novel Agents in Development
5. Rib-X Pharmaceuticals to Present at 10th Annual Superbugs & Superdrugs Conference
6. Ortho Biotech Statement on U.S. Food and Drug Administration Oncologic Drugs Advisory Committee Vote
7. NexGenix Pharmaceuticals Presents Data on a Novel Small Molecule Inhibitor of Heat Shock Protein 90 (Hsp90) at the GTCbio Cancer Drugs Research & Development Conference
8. Micromet Announces the Publication of BiTE Antibody Review in Drugs of the Future
9. Powerful New Efficacy Data in Moderate and Severe Hypertensive Patients Supports FDA Approval of AVALIDE(R) (Irbesartan-Hydrochlorothiazide) as the First Combination Therapy for Initial Use in Patients Likely to Need Multiple Drugs to Achieve Their Blood
10. First High-Res 3-D Structures of Mammalian HSP90 Protein Solved, Key to Better Targets for AIDS, Sepsis, Cancer Drugs
11. Surface Logix Presents Positive Phase 1 Repeat-Dose Trial Data on SLx-4090 at The 16th International Symposium on Drugs Affecting Lipid Metabolism

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...,Md.,Nov.24/PRNewswire/--Inadditiontofamily,friend...adelphiajurorstoherThanksgivinggratitudelist. ,...kfultothem,"shesaidofMonday,sverdictstotaling$103m...Wisneskiisamong12,000womennationwidewhohavesuedWye...pydrugsPremarinandPrempro.Wisneskiandtheothervicti...
(Date:11/24/2009)...D,Conn.,Nov.24/PRNewswire/--ZargisMedicalCorp.,asu...romSiemensCorporateResearch(NYSE: SI ),todayannoun...vember24,2009episodeofCBS, TheEarlyShow duringaseg...agazine,reviewedfivewinningproductsfromthepublicat...how isawidely-viewedtelevisionmorningnewstalkshowb...
(Date:11/24/2009)...ECITY,Nov.24/PRNewswire/-- InfiniteMind ,aSaltLake...nlinevisiontherapyprogrameyeQ,thesoftwareprogramis...ethods. ,, eyeQ wasintroducedattheCOVDconferen...ect,Dr.BradHabermehlbelievesthe eyeQ programaddssi...nFlintMichigan.Itallowshispatientstoembedpractices...
Breaking Medicine Technology:Maryland Woman Thankful for Wyeth Verdicts 2Zargis Cardioscan(TM) Featured on The Early Show on CBS 2Zargis Cardioscan(TM) Featured on The Early Show on CBS 3Infinite Mind Announces the Launch of a New Online Vision Therapy Program eyeQ 2Wolves lose their predatory edge in mid life new U of Minnesota study shows 60083 1Wolves lose their predatory edge in mid life new U of Minnesota study shows 60083 2Blue light filtering increases macular pigment may protect against age related vision loss 10527 1Blue light filtering increases macular pigment may protect against age related vision loss 10527 2Blue light filtering increases macular pigment may protect against age related vision loss 10527 3Blue light filtering increases macular pigment may protect against age related vision loss 10527 4NCI awards 2415 2 million to create Princeton Physical Sciences Oncology Center 10525 1NCI awards 2415 2 million to create Princeton Physical Sciences Oncology Center 10525 2NCI awards 2415 2 million to create Princeton Physical Sciences Oncology Center 10525 3NCI awards 2415 2 million to create Princeton Physical Sciences Oncology Center 10525 4
...RBOR, Mich., Feb. 19 Compendia Bioscience, Inc.,t..., including a renewed,and expanding commitment fro..."Top 20" oncology drug companies to its customer r...mitment expansions led to a greater than,300% reve...008., (Logo: http://www.newscom.com/cgi-bin/prnh...
...SLEY HILLS, Mass., Feb. 19 Joseph F. Finn, Jr.,CP...tivBiotics, announced,today the design of a clinic...reated adequately by currently approved antibiotic...t that has been administered to people, may,provid... insidious aspect,of Chlamydia STD is that infecti...
Other Medicine Technology:On Second Anniversary, Compendia Bioscience Announces Significant Revenue Growth, Completion of Product Milestone and Expansion of Pharma Customer Commitments 2On Second Anniversary, Compendia Bioscience Announces Significant Revenue Growth, Completion of Product Milestone and Expansion of Pharma Customer Commitments 3ActivBiotics Outlines a Clinical Path Forward to Examine if Rifalazil Is Superior to Azithromycin in the Treatment of Chlamydia STD 2
(Date:11/25/2009)..., WorkingTogethertoShareRecordsSafely,ImproveCar...--TheDepartmentofVeteransAffairs(VA)andKaiserPerma...ovecareandservicestoourNation,sheroes.VAandKaiserP...onichealthrecord(EHR)informationusingtheNationwide...ntofHealthandHumanServices. ,, "Theabilitytosha...
(Date:11/25/2009)..., GiftistheLargestDonationEverMadeinSupportofFeed....25/PRNewswire-USNewswire/--FeedingAmerica,thenati...da$1milliondonationfromtheBankofAmericaCharitableF...low-incomeAmericanswiththeSupplementalNutritionAss...ram.ThefundswillbeusedtohelpFeedingAmericafoodbank...
(Date:11/25/2009)...USTON - Two signaling pathways essential to normal...idermal growth factor receptor (EGFR) pathways - i...on and metastasis, researchers from The University...he Nov. 25 issue of Molecular Cell . , This new...ing components known to correlate with invasive ca...
(Date:11/25/2009)...ANGELES (Nov. 25, 2009) Melvin R. Kaplan, MD, FAC... the research institute that became Los Angeles Bi... Center (LA BioMed), will be honored by the Americ... to the care of patients. , At its April 22, 201...icians will present Dr. Kaplan with the Ralph O. C...
(Date:11/25/2009)...AS Nov. 25, 2009 Physicians at UT Southwestern M...ice designed to improve breathing in patients with... keep them from breathing independently. , UT S...one of only two sites in Texas and one of 25 in th..., called the NeuRx Diaphragm Pacing System. , Th...
Breaking Medicine News(10 mins):Health News:VA and Kaiser Permanente Invite Veterans to Participate in Health Record Pilot Program 2Health News:Bank of America Charitable Foundation Presents $1 Million Contribution to Feeding America in an Effort to Help Connect Low-Income Americans With Federal Nutrition Programs 2Health News:Bank of America Charitable Foundation Presents $1 Million Contribution to Feeding America in an Effort to Help Connect Low-Income Americans With Federal Nutrition Programs 3Health News:Crosstalk between critical cell-signaling pathways holds clues to tumor invasion and metastasis 2Health News:Crosstalk between critical cell-signaling pathways holds clues to tumor invasion and metastasis 3Health News:1 of LA BioMed's founders to be honored 2Health News:New device implanted by surgeons help paralyzed patients breathe easier 2
...finds that obesity increases the risk of death fro...e the overall risk a man will be diagnosed with th...ER, a peer-reviewed journal of the American Cancer...ate cancer. However, no such association was found...
...very adult these days knows that a diet laden with...r exercise and risky behaviors like smoking is a r...heart attacks. But a renowned heart disease resear...The fix is free. That’s because it costs nothing t...
...ed to test a medical device in a clinic at Clevela...tter to this effect was sent to U.S. Department of... A neurosurgeon was conducting an experiment to...zed subsequently. A letter describing this event h...
...vernment officials are worried about the lack of n...g women.// Previous research has linked the ... brain and spine. The research had also led to bre...1999 and 2004 showed that more than 50% of the 450...
...ducted by Dana-Farber Cancer Institute in Boston, ... chemotherapy drugs need to be monitored, prescrib... cases of unfortunate events, sourced from the ins... a consensus in the oncology field on standardized...
...s project, sponsored by the Canadian Institute of ...troke Foundation of Canada, have found that men an...ir heart disease. According to the study resul...usually effective in pinpointing heart problems in...
Other Medicine News:Health News:Excess Weight and Adult Weight Gain Increase Risk of Prostate Cancer Death 2Health News:Cure for Most Heart Attacks Is Free, but It's Important to Start Young 2Health News:Cure for Most Heart Attacks Is Free, but It's Important to Start Young 3Health News:Watchdog to Be Set on Oral Chemotherapy, Warns Experts 2
... Laboratories is a national reference laboratory a...earch and development. ARUP offers an extensive te... in clinical and anatomic pathology. Owned by the ...lude more than half of the nation's university tea...
... Laboratories is a national reference laboratory a...earch and development. ARUP offers an extensive te... in clinical and anatomic pathology. Owned by the ...lude more than half of the nation's university tea...
... Laboratories is a national reference laboratory a...earch and development. ARUP offers an extensive te... in clinical and anatomic pathology. Owned by the ...lude more than half of the nation's university tea...
... Laboratories is a national reference laboratory a...earch and development. ARUP offers an extensive te... in clinical and anatomic pathology. Owned by the ...lude more than half of the nation's university tea...
Medicine Products: